Skip to main content
CML-CP: Addition of PegIFN- to dasatinib well tolerated and effective in long term treatment
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CML-CP: Addition of PegIFN- to dasatinib well tolerated and effective in long term treatment
User login
Username
Password
Reset your password
Type
Lead
score
Edit Tags